Ocular surface and tear film abnormalities in women under adjuvant chemotherapy for breast cancer with the 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) regimen.

Karamitsos, A; Kokkas, V; Goulas, A; Paraskevopoulos, P; Gougoulias, K; Karampatakis, V; Boboridis, K

Karamitsos, A; Kokkas, V; Goulas, A; Paraskevopoulos, P; Gougoulias, K; Karampatakis, V; Boboridis, K.

Afiliação

Karamitsos A; 1 University Ophthalmology Department, AHEPA Hospital, Aristotle University of Thessaloniki.
Kokkas V; Pharmacology Department, Medical School, Aristotle University of Thessaloniki.
Goulas A; Pharmacology Department, Medical School, Aristotle University of Thessaloniki.
Paraskevopoulos P; Oncology Department, Theageneio Cancer Hospital.
Gougoulias K; Laboratory of Experimental Ophthalmology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Karampatakis V; Laboratory of Experimental Ophthalmology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Boboridis K; 1 University Ophthalmology Department, AHEPA Hospital, Aristotle University of Thessaloniki.

Hippokratia ; 17(2): 120-5, 2013 Apr.

Article em En | MEDLINE | ID: mdl-24376315

Palavras-chave

5-fluorouracil; Breast cancer; chemotherapy; cyclophosphamide; epirubicin; ocular surface; tear film

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: Hippokratia Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google